Repositioning Candidate Details
| Candidate ID: | R0425 |
| Source ID: | DB04830 |
| Source Type: | investigational; withdrawn |
| Compound Type: | small molecule |
| Compound Name: | Buformin |
| Synonyms: | |
| Molecular Formula: | C6H15N5 |
| SMILES: | CCCC\N=C(/N)N=C(N)N |
| Structure: |
|
| DrugBank Description: | Buformin is an anti-diabetic drug of the biguanide class, chemically related to metformin and phenformin. It was withdrawn from the market in most countries due to a high risk of causing lactic acidosis. |
| CAS Number: | 692-13-7 |
| Molecular Weight: | 157.2168 |
| DrugBank Indication: | |
| DrugBank Pharmacology: | |
| DrugBank MoA: | |
| Targets: | |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|